ARYX Therapeutics aryx.com


Public list: Smart Money VCs (6327) Pharma Startups (4514)

ARYx Therapeutics is a privately-held pharmaceutical research and development company focused on addressing safety concerns in well-established and commercially successful existing therapies through application of its proprietary ARYx RetroMetabolic (ARM) drug design. ARYx improves today's drugs, making proven therapies safer. ARYx currently has three products in clinical trials. For more information, please see the company's web site at www.aryx.com.

ARYx Therapeutics is a privately-held pharmaceutical research and development company focused on addressing safety concerns in well-established and commercially successful existing therapies through application of its proprietary ARYx RetroMetabolic ...Show all

Company (IPO / Went public)

Phone: 510-585-2200

Fax:

6300 Dumbarton Circle

Fremont, 94555
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ARYX Therapeutics $132M Nov 5, 2008
See all 21 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ARYX Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 12 investors

Competitors

Company Status Description Investors

Intarcia Therapeutics

Boston, Massachusetts, United States
Alive / ActiveIntarcia Therapeutics is a biopharmaceutical company developing therapies to ensure the best treatment outcome by optimizing patient convenience and adherence. Intarcia is addressing challenging diseases that require long-term chronic therapy by enhancing efficacy and reducing the burden therapies often place on the patient's life. Intarcia's drug development expertise and competitive edge is demonstrated by its ability to stabilize macromolecules and to deliver them in a constant and consistent...Show allLogin to see details

TruSource Technologies

Little Rock, Arkansas, United States
Alive / ActiveTruSource Technologies, LLC has developed a patent-pending, anti-counterfeit sensor which it will market to pharmaceutical companies to protect their high-dollar, high-volume prescription drugs. These nano-composite sensors will generate additional revenues for pharmaceutical companies and protect their brand equity while protecting the heath and safety of consumers.Login to see details
See all 21 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Materials and methods for the treatment of gastroesophageal reflux disease Dec 21, 2007 May 31, 2011 Patent
Ultrashort acting hypnotic barbiturates Dec 20, 2007 Apr 27, 2010 Patent
5-ht3 receptor antagonists and methods of use Oct 20, 2006 Mar 10, 2009 Patent